SRX
LIVE

Serial Number

87090985

Owner

SyneuRx International Corp.

Attorney

Paul Cosmovici

First Use Date

Mar 14, 2016

Filing Date

Jul 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

SRX Trademark

Serial Number: 87090985 • Registration: 5419036

SRX is a trademark filed by SyneuRx International Corp. on July 1, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SyneuRx International Corp. (5 trademarks)

21F.-2, No.510, Sec. 5
Taipei City 110 , TW

Entity Type: 03

Trademark Details

Filing Date

July 1, 2016

Registration Date

March 6, 2018

First Use Anywhere

March 14, 2016

First Use in Commerce

March 14, 2016

Published for Opposition

May 23, 2017

Goods & Services

Pharmaceutical products and substances for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; medicines for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; pharmaceutical preparations for neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; sodium salts for medical purposes

[ Pharmaceutical preparations and drug development services for developing drugs for treating neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Biological research; Clinical lab test of medical reagents for conducting clinical trials for others in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific research and analysis in the field of medical reagents; Providing research and development of technology in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical research in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Technical project studies in the field of neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, bipolar disorder, and other central nervous system disorders; Scientific laboratory services ]

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Oct 2, 2024 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Oct 2, 2024 8.PR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 25, 2024 APRE
TEAS SECTION 8 RECEIVED
Feb 21, 2024 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 6, 2023 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 28, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 28, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 28, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 28, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 28, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 28, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 23, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 6, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 31, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 30, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 30, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 30, 2018 AITU
USE AMENDMENT FILED
Jan 18, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 18, 2018 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 18, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 23, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 23, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 3, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2016 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2016 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 12, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 6, 2016 NWOS
NEW APPLICATION ENTERED
Jul 5, 2016 NWAP